Pallas Health vs Sprout Health: Brand options vs Fast Approval
Pallas Health vs Sprout Health is a matchup between a clinician-led service that offers brand-name GLP-1s plus compounded options and a fast-entry provider focused on quick approval and an introductory discount. Quick verdict: choose Pallas Health if you want access to brand-name pens or clinician-selected compounded semaglutide with an all-in plan price; choose Sprout Health if you prioritize lightning-quick approval and a first-month discount.
How they differ at a glance
Both operate online and are cash-pay only, but the evidence shows distinct contrasts in medication options, pricing structure, approval speed, and messaging about outcomes and compounding. The sections below compare these differences directly using only supplied facts.
Pallas Health vs Sprout Health: Medication options and compounding
Pallas Health documents that a US-licensed clinician personalizes plans and can select FDA-approved Wegovy, Ozempic, Zepbound and Mounjaro or compounded semaglutide and tirzepatide prepared in the USA when a brand medication is not the right fit. Sprout Health is described as prescribing compounded semaglutide and, per the source, does not offer branded Ozempic or Wegovy. Both note that compounded medications are not FDA-approved.
Pricing: first month, renewal cadence, and how costs are presented
Pallas lists compounded semaglutide at $139 for the first month, then $597 every 12 weeks (a $199/month average), and compounded tirzepatide at $179 first month, then $897 every 12 weeks ($299/month average). Pallas also lists cash-pay brand prices for Wegovy, Ozempic, Zepbound and Mounjaro with specific monthly figures. Sprout Health offers $50 off the first month, bringing the initial cost to $199, with an ongoing rate of $249/month after the discount. Sprout’s source emphasizes the post-discount ongoing rate is higher than several competitors.
Compare Pallas medication choices
Onboarding speed and experience
Sprout Health is presented as having a lightning-quick approval process and a fast, low-friction entry to GLP-1 therapy. Pallas is 100% online and asynchronous in most states, noting that 43 of 50 states need no video visit, but the source emphasizes clinician review and personalization rather than speed as the core feature.
Outcome messaging and guarantees
Sprout frames outcomes as 10 to 26 percent body weight loss over 12 months in its marketing copy and highlights clear outcome framing, while also stating Sprout does not offer a formal outcome guarantee. Pallas does not provide a comparable outcome claim in the supplied evidence; its focus is on clinician selection of brand or compounded medications and plan features like included provider care and messaging.
Five-point comparison table
| Criteria | Pallas Health | Sprout Health |
|---|---|---|
| Medication options | FDA-approved Wegovy, Ozempic, Zepbound, Mounjaro and compounded semaglutide/tirzepatide | Compounded semaglutide only (no branded Ozempic or Wegovy listed) |
| First-month price (compounded semaglutide) | $139 first month | $199 first month after $50 off |
| Ongoing price | $597 per 12 weeks (about $199/mo avg) | $249/month after discount |
| Onboarding speed | 100% online; asynchronous in most states, clinician review required | Lightning-quick approval and fast entry |
| Outcome messaging | Clinician-personalized plans; no outcome percent claim in supplied evidence | Frames 10–26% body weight loss over 12 months; no formal guarantee |
Other practical differences
Pallas includes provider care, ongoing check-ins and messaging in an all-in plan price with no membership fee, free expedited discreet shipping, and notes clinicians determine eligibility. Pallas also clarifies that compounded medications are prepared by US-licensed compounding pharmacies and are not FDA-approved. Sprout highlights fast approval and a discount but the captured landing-page evidence for shipping, membership, and cancellation was not available in the supplied source.
Start Sprout Health with $50 off
Final comparison and recommendation
In the Pallas Health vs Sprout Health comparison, the most distinctive differences are medication choice (brand-name options at Pallas vs compounded-only at Sprout), first-month pricing and renewal cadence, onboarding speed, and how each frames outcomes. If you want clinician access to both FDA-approved pens and compounded alternatives with an all-in plan price and included provider care, Pallas Health is the supported choice. If you want the fastest approval and an introductory discount to begin quickly, Sprout Health is the supported choice.
Check Sprout Health offer details
Review Pallas Health clinician options
Choose Pallas Health if you need clinician-selected access to brand-name GLP-1s or clinician-personalized compounded semaglutide with an all-in plan price and included provider care. Choose Sprout Health if you prioritize lightning-quick approval and a $50 first-month discount followed by a $249/month ongoing rate. All statements above use only the supplied facts and qualifiers; where landing-page details were not captured for Sprout, the source did not verify shipping or cancellation terms.